NASHVILLE, Tenn. / Sep 30, 2024 / Business Wire / HealthStream (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, unveiled an array of CredentialStream® innovations at the NAMSS 2024 Conference. CredentialStream, an industry-leading Credentialing solution for healthcare organizations, continues to expand its market-leading capabilities.
“We are proud to announce these new credentialing, privileging, and enrollment innovations,” said Michael J. Sousa, Executive Vice President of Enterprise Applications at HealthStream. “Collectively, these new capabilities will enable our clients to accelerate time to revenue, rapidly validate credentials, and boost the provider experience.”
Key announcements include:
“We’re excited to showcase these industry-leading capabilities at NAMSS 2024,” said Sousa. “We believe that accelerating the onboarding process for providers—including a myriad of tasks across medical staff credentialing, privileging, enrollment, health plan credentialing, compliance training, EMR provisioning, CME management, and provider evaluation—can best be achieved with a single application that automates all of these tasks and delivers a one-stop for providers.”
HealthStream is presenting these groundbreaking innovations alongside its other premier products at NAMSS24 in Denver. Attendees are invited to explore the HealthStream booth at #603 and participate in the enlightening Solution Showcase presentation, “Credentialing and Privileging are Critical: Win with CredentialStream,” during the event on Monday, Sept 30, 2024, 11:45 a.m.-12:05 p.m. MDT in the Solution Showcase area in the exhibit hall.
About HealthStream
HealthStream (Nasdaq: HSTM) is the healthcare industry’s largest ecosystem of platform-delivered workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care. For more information, visit http://www.healthstream.com or call 800-521-0574.
This press release contains forward-looking statements that involve risks and uncertainties regarding HealthStream. This information has been included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such results or events predicted in these statements may differ materially from actual future events or results. These forward-looking statements are based on a variety of assumptions that may not be realized, and which are subject to significant risks and uncertainties, including that the anticipated financial and strategic benefits of the acquisition may not be realized, as well as risks and uncertainties referenced from time to time in the Company’s filings with the Securities and Exchange Commission.
Last Trade: | US$32.70 |
Daily Change: | 0.32 0.99 |
Daily Volume: | 109,882 |
Market Cap: | US$994.410M |
March 11, 2025 February 24, 2025 February 13, 2025 January 27, 2025 November 05, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load